Skip to content

Development and Application of a Predictive Model for Exercise-Induced Dehydration Risk in Women

Development and Application of a Predictive Model for Exercise-Induced Dehydration Risk in Women

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500109798
Enrollment
Unknown
Registered
2025-09-25
Start date
2025-10-01
Completion date
Unknown
Last updated
2025-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exercise-induced dehydration

Interventions

Exercise dehydration test:All exercise-induced dehydration tests will be conducted in a laboratory setting using a cycle ergometer (Monark 839E, Sweden). Throughout each exercise session, participants

Sponsors

Beijing Sport University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 30 Years

Inclusion criteria

Inclusion criteria: (1) Age 20–30 years; (2) Regular endurance training habit, defined as >=3 sessions/week (each >=30 minutes) for >6 months; (3) Regular menstrual cycles in the past year (30–35 days) without severe menstrual discomfort; (4) No participation in any clinical or nutritional intervention studies within 1 month prior to the experiment; (5) No clinically diagnosed diseases (including but not limited to cardiovascular disease, metabolic disorders, kidney disease, thyroid dysfunction, or polycystic ovary syndrome); (6) No smoking or heavy alcohol use; (7) Not taking hormonal medications, contraceptives, or other drugs that may affect hydration status; (8) Voluntary participation with signed informed consent and ability to adhere to the study protocol.

Exclusion criteria

Exclusion criteria: (1) Menstrual cycle disorders (including functional amenorrhea, polycystic ovary syndrome, etc.) or severe dysmenorrhea that affects exercise; (2) Presence of significant dehydration risk (e.g., recent fluid loss due to illness or training, or a prior medical history related to dehydration); (3) Diagnosed diseases affecting sweat secretion or hydration status (e.g., endocrine disorders, renal dysfunction or chronic kidney disease, anemia, etc.); (4) Requirement to take hormonal medications or contraceptives during the study period; (5) Allergic reactions to sweat patches or wearable sweat sensor patches.

Design outcomes

Primary

MeasureTime frame
Plasma Osmolality;Hematocrit;Hemoglobin;Sweat K+;Sweat Na+;Body weight;Ten urine items;

Secondary

MeasureTime frame
Estrogen;Progesterone;

Countries

China

Contacts

Public ContactQiu Junqiang

Beijing Sport University

qiujunqiang@bsu.edu.cn+86 138 0111 1074

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026